Gerdes S, et al. - The effectiveness and tolerability of the new aerosol foam of calcipotriol 50 µg/g plus betamethasone dipropionate 0.5 mg/g was evaluated (Cal/BD foam, Enstilar) in psoriasis vulgaris under daily practice conditions. Findings demonstrated convincing efficacy and tolerability profile of the new Cal/BD foam in daily practice, specifically in cases with severer disease manifestations.